Shruti Bhat PhD (Pharmaceutics), MBA, Lean Six Sigma Black Belt
  • Consulting
  • Case Studies
  • Workshops
  • Books
  • Hall of Fame
  • Learning Center
  • Patents
  • Publications
  • Contact

Cancer drug sales fast sliding !

11/9/2010

0 Comments

 
New cancer drugs are a top priority for most pharmaceutical companies these days, but the sector's sales trajectory has flattened as key medicines lose patent protection and new breakthrough products prove scarce.

U.S. sales of oncology drugs increased just 3.5 percent in the first nine months of this year, according to pharmaceutical market information company IMS Health.


The sector saw sales growth of 23 percent in 2006, after Roche Holding AG's Avastin was launched. It grew by 14 percent in 2007 and 9 percent in both 2008 and 2009.

"This is an unprecedented slowdown," IMS representatives said at the Reuters Health Summit. "Growth is largely being driven by pricing increases," as well as the entrance of lower-cost generic drugs. Read more... 

0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

© Copyright 1992- 2019 Dr. Shruti Bhat ALL RIGHTS RESERVED.
See Terms and Conditions on this site usage.
SHRUTI BHAT, CONTACT
Click to connect.
Created by Macro2Micro Media